These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39092443)

  • 1. Modular and automated synthesis of oligonucleotide-small molecule conjugates for cathepsin B mediated traceless release of payloads.
    Jin C; Li S; Vallis KA; El-Sagheer AH; Brown T
    RSC Chem Biol; 2024 Jul; 5(8):738-744. PubMed ID: 39092443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.
    Jin C; Ei-Sagheer AH; Li S; Vallis KA; Tan W; Brown T
    Angew Chem Weinheim Bergstr Ger; 2022 Mar; 134(13):e202114016. PubMed ID: 38505643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.
    Jin C; Ei-Sagheer AH; Li S; Vallis KA; Tan W; Brown T
    Angew Chem Int Ed Engl; 2022 Mar; 61(13):e202114016. PubMed ID: 34953094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Methodology for the Synthesis of a Cathepsin B Cleavable Dipeptide Linker, Widely Used in Antibody-Drug Conjugate Research.
    Mondal D; Ford J; Pinney KG
    Tetrahedron Lett; 2018 Oct; 59(40):3594-3599. PubMed ID: 31156276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-Stage Desulfurization Enables Rapid and Efficient Solid-Phase Synthesis of Cathepsin-Cleavable Linkers for Antibody-Drug Conjugates.
    Ahangarpour M; Brimble MA; Kavianinia I
    Bioconjug Chem; 2024 Jul; 35(7):1007-1014. PubMed ID: 38874557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linker Architectures as Steric Auxiliaries for Altering Enzyme-Mediated Payload Release from Bioconjugates.
    Giese M; Davis PD; Woodman RH; Hermanson G; Pokora A; Vermillion M
    Bioconjug Chem; 2021 Oct; 32(10):2257-2267. PubMed ID: 34587447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates.
    Schuster S; Juhász É; Halmos G; Neundorf I; Gennari C; Mező G
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-amino acid linkers enable highly potent small molecule-drug conjugates by conditional release.
    Zheng Y; Xu R; Cheng H; Tai W
    Mol Ther; 2024 Apr; 32(4):1048-1060. PubMed ID: 38369752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.
    Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R
    Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs.
    Kern JC; Dooney D; Zhang R; Liang L; Brandish PE; Cheng M; Feng G; Beck A; Bresson D; Firdos J; Gately D; Knudsen N; Manibusan A; Sun Y; Garbaccio RM
    Bioconjug Chem; 2016 Sep; 27(9):2081-8. PubMed ID: 27469406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates.
    Watanabe T; Arashida N; Fujii T; Shikida N; Ito K; Shimbo K; Seki T; Iwai Y; Hirama R; Hatada N; Nakayama A; Okuzumi T; Matsuda Y
    J Med Chem; 2024 Oct; 67(20):18124-18138. PubMed ID: 39410752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates.
    Bryden F; Martin C; Letast S; Lles E; Viéitez-Villemin I; Rousseau A; Colas C; Brachet-Botineau M; Allard-Vannier E; Larbouret C; Viaud-Massuard MC; Joubert N
    Org Biomol Chem; 2018 Mar; 16(11):1882-1889. PubMed ID: 29473076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
    Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG
    Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil elastase as a versatile cleavage enzyme for activation of αvβ3 integrin-targeted small molecule drug conjugates with different payload classes in the tumor microenvironment.
    Rebstock AS; Wiedmann M; Stelte-Ludwig B; Wong H; Johnson AJ; Izumi R; Hamdy A; Lerchen HG
    Front Pharmacol; 2024; 15():1358393. PubMed ID: 38495100
    [No Abstract]   [Full Text] [Related]  

  • 15. Modular Smart Molecules for PSMA-Targeted Chemotherapy.
    Olatunji FP; Pun M; Herman JW; Romero O; Maniatopoulos M; Latoche JD; Parise RA; Guo J; Beumer JH; Anderson CJ; Berkman CE
    Mol Cancer Ther; 2022 Nov; 21(11):1701-1709. PubMed ID: 35999662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiol-Specific Linkers for the Synthesis of Oligonucleotide Conjugates via Metal-Free Thiol-Ene Click Reaction.
    Malinowska AL; Huynh HL; Correa-Sánchez AF; Bose S
    Bioconjug Chem; 2024 Sep; 35(10):1553-67. PubMed ID: 39264307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody drug conjugates beyond cytotoxic payloads.
    Hobson AD
    Prog Med Chem; 2023; 62():1-59. PubMed ID: 37981349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the Scope of the Cleavable
    Aho A; Äärelä A; Korhonen H; Virta P
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, High-Yielding Solid-Phase Synthesis of Cathepsin-B Cleavable Linkers for Targeted Cancer Therapeutics.
    Pryyma A; Gunasekera S; Lewin J; Perrin DM
    Bioconjug Chem; 2020 Dec; 31(12):2685-2690. PubMed ID: 33274932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfatase-cleavable linkers for antibody-drug conjugates.
    Bargh JD; Walsh SJ; Isidro-Llobet A; Omarjee S; Carroll JS; Spring DR
    Chem Sci; 2020 Jan; 11(9):2375-2380. PubMed ID: 34084399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.